GENB Generate Biomedicines, Inc.

Fundamentals / CIK 0002100782 / USD

Generate Biomedicines, Inc. reported $515.9M in total assets through September 30, 2026 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open GENB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

No annual income statement rows are available in SEC EDGAR CompanyFacts for GENB.

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Revenue $4.22M $6.31M $7.22M $9.63M $10.13M $8.82M
Research & Development $82.25M $64.33M $57.81M $62.15M $59.73M $46.83M
Total Operating Expenses $95.73M $77.93M $71.34M $72.45M $70.28M $56.97M
Operating Income -$91.51M -$71.61M -$64.11M -$62.81M -$60.15M -$48.15M
EBITDA -$87.81M -$68.41M -$60.84M -$59.51M -$56.85M -$44.74M
Interest Income $4.15M $4.63M $2.91M $3.10M $3.79M $4.28M
Interest Expense $192K $155K $182K $253K $307K $368K
Income Before Tax -$87.61M -$67.20M -$61.69M -$60.00M -$56.70M -$44.26M
Income Tax Expense $49K $53K $28K $34K $44K $56K
Net Income -$87.66M -$67.25M -$61.45M -$53.62M -$52.43M -$41.69M
Basic EPS -$0.68 -$0.52 -$1.07 -$1.97 -$1.94 -$1.62
Diluted EPS -$0.68 -$0.52 -$1.07 -$1.97 -$1.94 -$1.62
Basic Shares Outstanding 128.5M 128.2M 64.9M 33.0M 33.0M 32.8M
Diluted Shares Outstanding 128.5M 128.2M 64.9M 33.0M 33.0M 32.8M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

No annual balance sheet rows are available in SEC EDGAR CompanyFacts for GENB.

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31
Cash & Cash Equivalents $140.3M $135.4M $160.6M $121.7M
Short-Term Investments $263.9M $322.1M $356.1M $99.85M
Cash & Short-Term Investments $404.2M $457.4M $516.6M $221.5M
Total Current Assets $414.6M $470.3M $535.4M $234.4M
Property, Plant & Equipment, Net $38.65M $27.30M $27.84M $29.15M
Other Non-Current Assets $9.34M $9.06M $4.75M $6.81M
Total Non-Current Assets $101.2M $91.44M $90.35M $95.82M
Total Assets $515.9M $561.7M $625.7M $330.2M
Accounts Payable $7.89M $5.65M $7.62M $3.84M
Deferred Revenue (Current) $7.95M $12.17M $17.24M $21.19M
Other Current Liabilities $3.16M $2.52M $2.42M $2.63M
Total Current Liabilities $82.72M $56.64M $58.39M $82.20M
Deferred Revenue (Non-Current) $0 $0 $1.24M $4.51M
Other Non-Current Liabilities $0 $0 $0 $116K
Total Non-Current Liabilities $52.01M $49.01M $52.55M $59.35M
Total Liabilities $134.7M $105.6M $110.9M $141.6M
Total Debt (incl. Leases) $75.34M $62.63M $65.57M $68.53M
Common Stock $129K $128K $128K $33K
Retained Earnings -$892.7M -$805.0M -$737.7M -$676.3M
Accumulated Other Comp. Income -$264K -$129K $24K $106K
Total Stockholders' Equity $381.2M $456.0M $514.8M -$616.0M
Total Equity $381.2M $456.0M $514.8M -$616.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

No annual cash flow statement rows are available in SEC EDGAR CompanyFacts for GENB.

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Net Income -$87.66M -$67.25M -$61.71M -$60.03M -$56.74M -$44.31M
Depreciation & Amortization $3.70M $3.20M $3.27M $3.30M $3.30M $3.41M
Stock-Based Compensation $8.06M $8.24M $6.39M $4.82M $5.49M $4.74M
Change in Receivables $0 $0 $0 -$105K $59K -$91K
Change in Payables $2.24M -$1.95M $3.75M $2.09M $446K -$597K
Operating Cash Flow -$54.86M -$57.94M -$80.39M -$48.43M -$48.75M -$53.18M
Capital Expenditure -$2.15M -$933K -$3.78M -$235K -$154K -$751K
Free Cash Flow -$57.01M -$58.88M -$84.17M -$48.66M -$48.91M -$53.93M
Purchases of Investments -$147.5M -$606K -$321.2M -$22.22M -$65.16M -$77.35M
Investing Cash Flow $56.36M $33.31M -$259.9M $9.18M -$17.07M $75.53M
Financing Cash Flow $3.49M -$579K $378.9M $3.79M -$263K $20.56M
Net Change in Cash $4.99M -$25.21M $38.57M -$35.46M -$66.08M $42.92M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

No annual ratios & growth rows are available in SEC EDGAR CompanyFacts for GENB.

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-09-30 2025-06-30 2025-03-31
Current Ratio 5.01x 8.30x 9.17x -- -- --
Quick Ratio 4.89x 8.08x 8.85x -- -- --
Debt to Equity 0.20x 0.14x 0.13x -- -- --
Revenue Growth (YoY) -56.2% -37.7% -18.1% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0002100782) · from March 31, 2025 Data through September 30, 2026 · synced Nov 20, 2026, 05:24 UTC · Open in terminal